The BSH Guidelines Official Podcast

Lymphoma SIG Podcast 8 - Bispecific T-cells engagers in Lymphoma

Dr Sridhar Chaganti discusses the use of bispecific T-cell engagers (BITE’s) in large B-cell lymphoma.  

Dr Chaganti is a consultant haematologist at University Hospitals Birmingham NHS Foundation Trust. He has a PhD in cancer studies from the University of Birmingham.

His research interest is Epstein–Barr virus (EBV) and lymphomas. His special interests are in haematological malignancies, lymphomas, stem cell transplantation and cellular therapies.

Lymphoma SIG Podcast 7 - Supportive Care in Lymphoma

Dr Nikesh (Nik) Chavda discusses supportive care in lymphoma.

Dr Chavda is a haematology consultant at University Hospitals Bristol and Weston, with an interest in B-cell malignancies, cellular therapies and histiocytic disorders.

Lymphoma SIG Podcast 6 - Mycosis fungoides

Dr Duncan Murray discusses mycosis fungoides and sezary syndrome.

Dr Murray completed his PhD at the University of Birmingham, looking at the interaction between the immune system and malignant T cells in skin lymphoma.

He finds the interaction between a "good" and "bad" T cell fascinating. He has used multiple single-cell laboratory techniques to tease apart the two populations (including V-beta antibodies, single-cell T-cell receptor (TCR) and ribonucleic acid (RNA) sequencing and mass cytometry).

Skin lymphoma is an unusual disease in that key determinants of the patient's outcome sit very close together. Both anatomically and in phenotype. His current work focuses on what we can learn from high-dimensional single-cell data and the bioinformatic process to assist this.

Lymphoma SIG Podcast 5 - T-cell lymphomas

Dr Matthew Ahearne is a consultant haematologist at University Hospitals of Leicester NHS Trust. His main clinical and research focus is on T-cell lymphomas.

Dr Ahearne is Deputy Chair of the National Cancer Research Institute (NCRI) T-cell lymphoma working group and an NCRI Lymphoma Science sub-group member.

Lymphoma SIG Podcast 4 - Management of post-transplant lymphoproliferative disorder

Dr Sridhar Chaganti discusses the current management of post-transplant lymphoproliferative disorder (PTLD), including subtypes, prognostic factors and the current treatment options.

He explores the role of immunotherapy, cytotoxic agents and the emerging field of cellular therapies in this group of patients.

Dr Chaganti is a consultant haematologist at University Hospitals Birmingham NHS Foundation Trust. He has a PhD in cancer studies from the University of Birmingham.

His research interest is Epstein–Barr virus (EBV) and lymphomas. His special interests are in haematologic malignancies, lymphomas and stem cell transplantation.

Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma GPP

Dr Aisling Barrett discusses the guideline on Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma

 

 

Advanced imaging for earlier diagnosis and morbidity prevention in multiple myeloma: A British Society of Haematology and UK Myeloma Society Good Practice Paper

Professor Martin Kaiser & Dr Ceri Bygrave discuss the Advanced imaging for earlier diagnosis and morbidity prevention in multiple myeloma guideline.

 

 

Diagnosis and initial treatment of transplant-eligible high-risk myeloma patients

Professor Martin Kaiser and Dr Matthew Jenner discuss the BSH Good Practice Paper for the diagnosis and initial treatment of transplant-eligible high-risk myeloma patients, published in July 2024.

2024-11-06-Podcast-Keith_Gomez-Cancer_Associated_Venous-Thrombosis

Guideline for the Management of Conception and Pregnancy in Thalassaemia Syndromes

Dr Amma Kyei Mensah, Dr Sarah Nicolle and Dr Farrukh Shah discuss the BSH Guideline for the management of conception and pregnancy in thalassaemia syndromes, published in 2024.